Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Stopped early · Phase 2

Conditions studied: Precancerous/Nonmalignant Condition, Prostate Cancer

In brief

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of calcitriol may prevent prostate cancer. It is not yet known whether calcitriol is more effective than observation in preventing prostate cancer. PURPOSE: This randomized phase II trial is studying how well calcitriol works in preventing prostate cancer in patients with prostatic intraepithelial neoplasia.

Key facts

Study ID

NCT00118066

Run by

Rutgers, The State University of New Jersey

People needed

12

Starts

2004-05-01

Expected to finish

2011-08-01

Last updated by the study team

2015-05-27

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Central Jersey Oncology Center, PA - East Brunswick — East Brunswick, New Jersey, United States
• Carol G. Simon Cancer Center at Morristown Memorial Hospital — Morristown, New Jersey, United States
• Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
• Saint Peter's University Hospital — New Brunswick, New Jersey, United States
• Overlook Hospital — Summit, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.